Patents by Inventor Gary Kaplan

Gary Kaplan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060247619
    Abstract: This relates to methods and devices for achieving contact between the wall of a cavity or passageway and a medical device under conditions in which an access path and the subject anatomy are not aligned.
    Type: Application
    Filed: May 25, 2006
    Publication date: November 2, 2006
    Applicant: ASTHMATX, INC.
    Inventors: Gary Kaplan, Christopher Danek, William Wizeman, Tim Dalbec
  • Publication number: 20060247618
    Abstract: This relates to methods and devices for achieving contact between the wall of a cavity or passageway and a medical device under conditions in which an access path and the subject anatomy are not aligned.
    Type: Application
    Filed: May 25, 2006
    Publication date: November 2, 2006
    Applicant: ASTHMATX, INC.
    Inventors: Gary KAPLAN, Christopher DANEK, William WIZEMAN, Tim DALBEC
  • Publication number: 20060247617
    Abstract: This relates to methods and devices for improving treatment to a wall, a cavity or passageway with a medical device when used in tortuous anatomy.
    Type: Application
    Filed: May 25, 2006
    Publication date: November 2, 2006
    Applicant: Asthmatx, Inc.
    Inventors: Christopher DANEK, Gary Kaplan, William Wizeman, Michael Laufer
  • Publication number: 20060247746
    Abstract: Control systems and methods for delivery of energy that may include control algorithms that prevent energy delivery if a fault is detected and may provide energy delivery to produce a substantially constant temperature at a delivery site. In some embodiments, the control systems and methods may be used to control the delivery of energy, such as radiofrequency energy, to body tissue, such as lung tissue.
    Type: Application
    Filed: April 21, 2006
    Publication date: November 2, 2006
    Applicant: Asthmatx, Inc.
    Inventors: Christopher Danek, William Wizeman, Tim Dalbec, Gary Kaplan
  • Publication number: 20060137698
    Abstract: This relates to treating an asthmatic lung and more particularly, relates to advancing a treatment device into the lung and treating the lung with the device. This also includes additional steps of treating the airway wall, applying energy or heat to the airway wall in an asthmatic lung.
    Type: Application
    Filed: February 23, 2006
    Publication date: June 29, 2006
    Applicant: Asthmatx, Inc.
    Inventors: Christopher Danek, Michael Biggs, Bryan Loomas, Michael Laufer, Gary Kaplan, Kelly Shriner
  • Publication number: 20060062808
    Abstract: Treatment and procedures for treating bodily conduits involves deactivating, killing, or otherwise treating smooth muscle tissue of the conduit.
    Type: Application
    Filed: September 30, 2004
    Publication date: March 23, 2006
    Applicant: Asthmatx, Inc.
    Inventors: Michael Laufer, David Auth, Christopher Danek, William Wizeman, Gary Kaplan
  • Publication number: 20050192526
    Abstract: Devices and methods are directed to improving the gaseous exchange in a lung of an individual having, for instance, chronic obstructive pulmonary disease. More particularly, conduits may be deployed in the lung to maintain collateral openings (or channels) surgically created through airway walls. This tends to facilitate both the exchange of oxygen ultimately into the blood and decompress hyper-inflated lungs.
    Type: Application
    Filed: December 7, 2004
    Publication date: September 1, 2005
    Inventors: Michael Biggs, Thomas Keast, Bryan Loomas, Don Tanaka, David Thompson, Gary Kaplan, Kelly Shriner, Halil Karabey, Russ Redmond, Claude Vida, Mike Collinson, Cary Cole, Michael Willink
  • Publication number: 20050137518
    Abstract: Devices and methods are directed to improving the gaseous exchange in a lung of an individual having, for instance, chronic obstructive pulmonary disease. More particularly, conduits may be deployed in the lung to maintain collateral openings (or channels) surgically created through airway walls. This tends to facilitate both the exchange of oxygen ultimately into the blood and decompress hyper-inflated lungs. The conduit includes a radially expandable center section having a first end, a second end, and a passageway extending from the first end to the second end. A control segment may be associated with the conduit to limit the degree of radial expansion. The conduit further includes a plurality of deflectable members extending from the ends of the center section. A tissue barrier may coaxially surround the conduit such that tissue ingrowth is prevented.
    Type: Application
    Filed: September 28, 2004
    Publication date: June 23, 2005
    Inventors: Michael Biggs, Thomas Keast, Bryan Loomas, Don Tanaka, David Thompson, Gary Kaplan, Kelly Shriner, Halil Karabey, Russ Redmond, Claude Vidal, Mike Collinson, Cary Cole, Michael Willink
  • Publication number: 20050137712
    Abstract: Devices and methods are directed to improving the gaseous exchange in a lung of an individual having, for instance, chronic obstructive pulmonary disease. More particularly, conduits may be deployed in the lung to maintain collateral openings (or channels) surgically created through airway walls. This tends to facilitate both the exchange of oxygen ultimately into the blood and decompress hyper-inflated lungs.
    Type: Application
    Filed: October 22, 2004
    Publication date: June 23, 2005
    Inventors: Michael Biggs, Thomas Keast, Bryan Loomas, Don Tanaka, David Thompson, Gary Kaplan, Kelly Shriner, Halil Karabey, Russ Redmond, Claude Vidal, Mike Collinson, Cary Cole, Michael Willink
  • Publication number: 20050096529
    Abstract: The methods and devices disclosed altering gaseous flow within a lung to improve the expiration cycle of individuals having Chronic Obstructive Pulmonary Disease.
    Type: Application
    Filed: November 1, 2004
    Publication date: May 5, 2005
    Applicant: Broncus Technologies, Inc.
    Inventors: Joel Cooper, Bryan Loomas, Don Tanaka, Michael Laufer, David Thompson, James Davenport, Gary Kaplan, Dave Haugaard, Glendon French
  • Publication number: 20050085801
    Abstract: The methods and devices disclosed altering gaseous flow within a lung to improve the expiration cycle of individuals having Chronic Obstructive Pulmonary Disease.
    Type: Application
    Filed: October 15, 2004
    Publication date: April 21, 2005
    Applicant: Broncus Technologies, Inc.
    Inventors: Joel Cooper, Bryan Loomas, Don Tanaka, Michael Laufer, David Thompson, James Davenport, Gary Kaplan, Dave Haugaard, Glendon French
  • Publication number: 20050049615
    Abstract: The methods and devices disclosed altering gaseous flow within a lung to improve the expiration cycle of individuals having Chronic Obstructive Pulmonary Disease.
    Type: Application
    Filed: October 15, 2004
    Publication date: March 3, 2005
    Applicant: Broncus Technologies, Inc.
    Inventors: Joel Cooper, Bryan Loomas, Don Tanaka, Michael Laufer, David Thompson, James Davenport, Gary Kaplan, Dave Haugaard, Glendon French
  • Publication number: 20040220556
    Abstract: The devices and methods of placement of such devices disclosed herein are directed to altering gaseous flow within a lung to improve the expiration cycle of, for instance, an individual having Chronic Obstructive Pulmonary Disease. More particularly, these devices produce and maintain collateral openings or channels through the airway wall so that oxygen depleted/carbon dioxide rich air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs. The medical kits disclosed herein are also directed to produce and maintain collateral openings through airway walls.
    Type: Application
    Filed: June 8, 2004
    Publication date: November 4, 2004
    Applicant: Broncus Technologies, Inc.
    Inventors: Joel D. Cooper, James M. Davenport, Bryan Loomas, Don Tanaka, Gary Kaplan
  • Publication number: 20040211434
    Abstract: This is directed to improving the gaseous exchange in a lung of an individual and particularly, this is directed to improving the gaseous exchange in individuals having chronic obstructive pulmonary disease. It generally includes fluidly connecting the lung to an extrapleural airway such as the trachea. In one variation, a conduit is deployed to place the lung and the trachea in fluid communication which allows trapped oxygen-reduced air to pass directly out of the lung and into the trachea. Removing nonfunctional air from the lung tends to improve the gaseous exchange of oxygen into the blood and decompress hyper-inflated lungs. Sealant and biocompatible adhesives may be provided on the exterior of the conduit to prevent side flow, leaks and to otherwise prevent air from entering spaces not intended to receive air such as the pleura space.
    Type: Application
    Filed: July 7, 2003
    Publication date: October 28, 2004
    Applicant: Broncus Technologies, Inc.
    Inventors: Bryan Loomas, Gary Kaplan
  • Publication number: 20040182399
    Abstract: This relates to treating an asthmatic lung and more particularly, relates to advancing a treatment device into the lung and treating the lung with the device. This also includes additional steps of treating the airway wall, applying energy or heat to the airway wall in an asthmatic lung.
    Type: Application
    Filed: March 26, 2004
    Publication date: September 23, 2004
    Applicant: Asthmatx, Inc.
    Inventors: Christopher James Danek, Michael Biggs, Bryan Loomas, Michael D. Laufer, Gary Kaplan, Kelly Shriner
  • Publication number: 20040073155
    Abstract: Devices and methods are directed to altering gaseous flow within a lung to improve the expiration cycle of, for instance, an individual having chronic obstructive pulmonary disease. More particularly, methods and devices are disclosed that inhibit closure of channels surgically created through an airway wall such that air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs. Devices, instruments, medicine, bioactive agents, or combinations thereof serve to maintain the patency of the surgically created channels. In one embodiment of the present invention, a conduit includes a bioactive coating that inhibits tissue overgrowth when the conduit is deployed in a surgically created channel. Still other methods and devices are described that serve to maintain surgically created channels.
    Type: Application
    Filed: June 9, 2003
    Publication date: April 15, 2004
    Applicant: Broncus Technologies, Inc.
    Inventors: Michael D. Laufer, Cary Cole, Bryan Loomas, Gary Kaplan, Cary J. Reich, Ed Roschak, Trudy Estridge
  • Publication number: 20040073201
    Abstract: The methods and devices disclosed altering gaseous flow within a lung to improve the expiration cycle of individuals having Chronic Obstructive Pulmonary Disease.
    Type: Application
    Filed: August 4, 2003
    Publication date: April 15, 2004
    Applicant: Broncus Technologies, Inc.
    Inventors: Joel D. Cooper, Bryan Loomas, Don Tanaka, Michael D. Laufer, David Thompson, James M. Davenport, Gary Kaplan, Dave Haugaard, Glendon E. French
  • Publication number: 20040031494
    Abstract: This relates to treating an asthmatic lung and more particularly, relates to advancing a treatment device into the lung and treating the lung with the device. This also includes additional steps of treating the airway wall, applying energy or heat to the airway wall in an asthmatic lung.
    Type: Application
    Filed: August 13, 2003
    Publication date: February 19, 2004
    Applicant: Broncus Technologies, Inc.
    Inventors: Christopher James Danek, Michael Biggs, Bryan Loomas, Michael D. Laufer, Gary Kaplan, Kelly Shriner
  • Patent number: 6692494
    Abstract: The devices and methods disclosed herein are directed to altering gaseous flow within a lung to improve the expiration cycle of, for instance, an individual having Chronic Obstructive Pulmonary Disease. More particularly, these devices and methods produce and to maintain collateral openings or channels through the airway wall so that expired air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs. The devices and methods also disclose locating and selecting a site for creation of a collateral opening.
    Type: Grant
    Filed: August 7, 2000
    Date of Patent: February 17, 2004
    Assignee: Broncus Technologies, Inc.
    Inventors: Joel D. Cooper, Bryan Loomas, Don Tanaka, Michael D. Laufer, David Thompson, James M. Davenport, Gary Kaplan, Dave Haugaard, Glendon E. French
  • Patent number: 6634363
    Abstract: This relates to treating a lung having at least one symptom of reversible obstructive pulmonary disease, and more particularly, relates to advancing a treatment device into the lung and treating the lung with the device to at least reduce the ability of the lung to produce at least one of the symptoms of reversible obstructive pulmonary disease. This also includes additional steps that reduce the ability of the lung to produce at least one of the symptoms of reversible obstructive pulmonary disease and to reduce the resistance to the flow of air through a lung.
    Type: Grant
    Filed: March 27, 2000
    Date of Patent: October 21, 2003
    Assignee: Broncus Technologies, Inc.
    Inventors: Christopher James Danek, Michael Biggs, Bryan Loomas, Michael D. Laufer, Gary Kaplan, Kelly Shriner